Shuilong Guo
- Molecular Biology
- Cancer Research top 5%
- Rehabilitation top 5%
- Oncology
- Surgery
- Topics
- MicroRNA in disease regulation (9 papers)RNA modifications and cancer (7 papers)Cancer-related molecular mechanisms research (6 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Shuilong Guo
24 papers receiving 913 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 565
- Cancer Research 424
- Rehabilitation 88
- Oncology 87
- Surgery 75
Countries citing papers authored by Shuilong Guo
This map shows the geographic impact of Shuilong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuilong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuilong Guo more than expected).
Fields of papers citing papers by Shuilong Guo
This network shows the impact of papers produced by Shuilong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuilong Guo. The network helps show where Shuilong Guo may publish in the future.
Co-authorship network of co-authors of Shuilong Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Shuilong Guo. A scholar is included among the top collaborators of Shuilong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuilong Guo. Shuilong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 13 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 47 | |
| 7 | 24 | |
| 8 | 4 | |
| 9 | 28 | |
| 10 | 14 | |
| 11 | 12 | |
| 12 | 9 | |
| 13 | 42 | |
| 14 | 8 | |
| 15 | 24 | |
| 16 | 96 | |
| 17 | 5 | |
| 18 | 172 | |
| 19 | 153 | |
| 20 | 95 |
About Shuilong Guo
Shuilong Guo is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Rehabilitation, having authored 26 papers that have together received 923 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (424 citations), Rehabilitation (88 citations) and Molecular Biology (565 citations). Shuilong Guo has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xiao Yang, Kaiji Fan, Yan Teng, Youliang Wang, Hailun Jiang, Rui Liu, Jianguo Xing, Shutian Zhang, Jun Wang and Jun Li. Their work appears in journals such as Nature Communications, Molecules and Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.